Association of baseline glycaemic status with BMD change after 12 doses of romosozumab: a retrospective cohort study of 170 patients.

Tsoi KH, Xiong X, Liu X, Wong CH, Fong CHY, Fung MMH, Leung EKH, Lee ACH, Ip TP, Tan KCB, Lee CH, Woo YC, Chandran M, Tsourdi E, Lui DTW

Open source

DOI: 10.3389/fendo.2026.1941784
Published: 2026
Container: Frontiers in endocrinology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1941784,
  title = {Association of baseline glycaemic status with BMD change after 12 doses of romosozumab: a retrospective cohort study of 170 patients.},
  author = {Tsoi KH and Xiong X and Liu X and Wong CH and Fong CHY and Fung MMH and Leung EKH and Lee ACH and Ip TP and Tan KCB and Lee CH and Woo YC and Chandran M and Tsourdi E and Lui DTW},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1941784},
  url = {https://doi.org/10.3389/fendo.2026.1941784}
}

RIS

TY  - JOUR
TI  - Association of baseline glycaemic status with BMD change after 12 doses of romosozumab: a retrospective cohort study of 170 patients.
AU  - Tsoi KH
AU  - Xiong X
AU  - Liu X
AU  - Wong CH
AU  - Fong CHY
AU  - Fung MMH
AU  - Leung EKH
AU  - Lee ACH
AU  - Ip TP
AU  - Tan KCB
AU  - Lee CH
AU  - Woo YC
AU  - Chandran M
AU  - Tsourdi E
AU  - Lui DTW
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1941784
UR  - https://doi.org/10.3389/fendo.2026.1941784
ER  -

APA

KH, T., X, X., X, L., CH, W., CHY, F., MMH, F., EKH, L., ACH, L., TP, I., KCB, T., CH, L., YC, W., M, C., E, T., & DTW, L. (2026). Association of baseline glycaemic status with BMD change after 12 doses of romosozumab: a retrospective cohort study of 170 patients.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1941784

Source records

pubmed · retrieved 2026-11-10T20:39:50.790Z